SecBot SecBot
SECBOTREPLAY Home › Report › RVMDW

RVMDW · Revolution Medicines is raising $500 million through a 0.50%…

Revolution Medicines, Inc. · 424B5 filed Apr 15, 2026 at 17:24 ET

At the news

BEARISHIMPACT 7/10

424B5 filed Apr 15, 2026 at 17:24 ET

Revolution Medicines is raising $500 million through a 0.50% convertible senior notes offering due 2033, with an additional concurrent $1.4 billion common stock offering. The notes offer a low interest rate and conversion into equity if the stock price exceeds 130% of the conversion price, but carry significant dilution risk and subordination in the capital structure.

  • Company is offering $500 million in 0.50% convertible senior notes due 2033
  • Concurrent common stock offering of $1.435 billion (up to $1.65 billion if option exercised)
  • Initial conversion price of $198.80 per share, representing a 35% premium to current stock price of $147.01
  • Notes are senior unsecured obligations, structurally subordinated to subsidiary liabilities

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access